Sökning: WFRF:(Hart Nigel) > Explaining variatio...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04652naa a2200529 4500 | |
001 | oai:DiVA.org:lnu-81976 | |
003 | SwePub | |
008 | 190415s2015 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-819762 URI |
024 | 7 | a https://doi.org/10.1136/bmjopen-2014-0072122 DOI |
040 | a (SwePub)lnu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Rose, Peter W.u Univ Oxford, UK4 aut |
245 | 1 0 | a Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership :b a primary care vignette survey |
264 | c 2015-05-27 | |
264 | 1 | b BMJ Publishing Group Ltd,c 2015 |
338 | a print2 rdacarrier | |
520 | a Objectives: The International Cancer Benchmarking Partnership (ICBP) is a collaboration between 6 countries and 12 jurisdictions with similar primary care-led health services. This study investigates primary care physician (PCP) behaviour and systems that may contribute to the timeliness of investigating for cancer and subsequently, international survival differences. Design: A validated survey administered to PCPs via the internet set out in two parts: direct questions on primary care structure and practice relating to cancer diagnosis, and clinical vignettes, assessing management of scenarios relating to the diagnosis of lung, colorectal or ovarian cancer. Participants: 2795 PCPs in 11 jurisdictions: New South Wales and Victoria (Australia), British Columbia, Manitoba, Ontario (Canada), England, Northern Ireland, Wales (UK), Denmark, Norway and Sweden. Primary and secondary outcome measures: Analysis compared the cumulative proportion of PCPs in each jurisdiction opting to investigate or refer at each phase for each vignette with 1-year survival, and conditional 5-year survival rates for the relevant cancer and jurisdiction. Logistic regression was used to explore whether PCP characteristics or system differences in each jurisdiction affected the readiness to investigate. Results: 4 of 5 vignettes showed a statistically significant correlation (p<0.05 or better) between readiness to investigate or refer to secondary care at the first phase of each vignette and cancer survival rates for that jurisdiction. No consistent associations were found between readiness to investigate and selected PCP demographics, practice or health system variables. Conclusions: We demonstrate a correlation between the readiness of PCPs to investigate symptoms indicative of cancer and cancer survival rates, one of the first possible explanations for the variation in cancer survival between ICBP countries. No specific health system features consistently explained these findings. Some jurisdictions may consider lowering thresholds for PCPs to investigate for cancer-either directly, or by specialist referral, to improve outcomes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Medicin | |
653 | a Medicine | |
700 | 1 | a Rubin, Gregu Univ Durham, UK4 aut |
700 | 1 | a Perera-Salazar, Rafaelu Univ Oxford, UK4 aut |
700 | 1 | a Almberg, Sigrun Sauru Norwegian Univ Sci & Technol, Norway4 aut |
700 | 1 | a Barisic, Andrianau Canc Care Ontario, Canada4 aut |
700 | 1 | a Dawes, Martinu Univ British Columbia, Canada4 aut |
700 | 1 | a Grunfeld, Evau Ontario Inst Canc Res, Canada;Univ Toronto, Canada4 aut |
700 | 1 | a Hart, Nigelu Queens Univ Belfast, UK4 aut |
700 | 1 | a Nea, Richard D.u Bangor Univ, UK4 aut |
700 | 1 | a Pirotta, Marieu Primary Hlth Care Res Evaluat & Dev, Australia4 aut |
700 | 1 | a Sisler, Jeffreyu Univ Manitoba, Canada4 aut |
700 | 1 | a Konrad, Geraldu Univ Manitoba, Canada4 aut |
700 | 1 | a Toftegaard, Berit Skjodebergu Aarhus Univ, Denmark4 aut |
700 | 1 | a Thulesius, Hansu Region Kronoberg, Sweden.4 aut0 (Swepub:lnu)hnthab |
700 | 1 | a Vedsted, Peteru Aarhus Univ, Denmark4 aut |
700 | 1 | a Young, Janeu Univ Sydney, Australia4 aut |
700 | 1 | a Hamilton, Willieu Univ Exeter, UK4 aut |
710 | 2 | a Univ Oxford, UKb Univ Durham, UK4 org |
773 | 0 | t BMJ Opend : BMJ Publishing Group Ltdg 5:5, s. 1-14q 5:5<1-14x 2044-6055 |
856 | 4 | u https://doi.org/10.1136/bmjopen-2014-007212y Fulltext |
856 | 4 | u https://bmjopen.bmj.com/content/5/5/e007212.full.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-81976 |
856 | 4 8 | u https://doi.org/10.1136/bmjopen-2014-007212 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.